InMed Pharmaceuticals Inc. SEC filings INM

InMed Pharmaceuticals Inc. has 514 filings in SEC EDGAR's recent list, going back to Jan 17, 2018. Its latest annual report, Form 10-K, was filed on Sep 9, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.

InMed Pharmaceuticals Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Nov 5, 2026 Nov 4, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
Nov 5, 2026 Nov 4, 2026
8-K Current report
Regulation FD disclosure
Nov 3, 2026 Nov 3, 2026
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
425 Filing Nov 2, 2026 —
424B3 Prospectus Oct 28, 2026 —
425 Filing Oct 27, 2026 —
EFFECT Filing Oct 1, 2026 —
424B3 Prospectus Oct 1, 2026 —
S-4/A Filing Sep 29, 2026 —
8-K Current report
Listing notice, Other events
Sep 18, 2026 Sep 16, 2026
S-4/A Filing Sep 9, 2026 —
425 Form 425 Sep 9, 2026 —
10-K Annual report Sep 9, 2026 Jun 30, 2026
425 Form 425 Jul 22, 2026 —
425 Current report Jul 22, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jul 22, 2026 Jul 22, 2026
425 Form 425 Jul 20, 2026 —
425 Current report Jul 10, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 10, 2026 Jul 6, 2026
S-4 Registration for a merger or exchange Jul 2, 2026 —
8-K Current report
Other events
Jun 10, 2026 Jun 3, 2026
425 Current report May 19, 2026 —
8-K Current report
Material agreement, Change in control, Officer or director change, Regulation FD disclosure
May 19, 2026 May 19, 2026
8-K Current report
Material agreement, Change to shareholder rights, Other events
May 19, 2026 May 18, 2026
8-K Current report
Regulation FD disclosure
May 7, 2026 May 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Material agreement, Change to shareholder rights, Other events
Apr 27, 2026 Apr 21, 2026
8-K Current report
Other events
Apr 3, 2026 Apr 3, 2026
424B5 Prospectus supplement Apr 3, 2026 —
EFFECT Filing Mar 30, 2026 —
8-K Current report
Listing notice
Mar 30, 2026 Mar 27, 2026
CORRESP Letter to the SEC Mar 26, 2026 —
UPLOAD Letter from the SEC Mar 25, 2026 —
8-K Current report
Regulation FD disclosure
Mar 23, 2026 Mar 23, 2026
S-3 Shelf registration Mar 20, 2026 —
8-K Current report
Regulation FD disclosure
Mar 9, 2026 Mar 9, 2026
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Mar 6, 2026 Mar 4, 2026
8-K Current report
Regulation FD disclosure
Feb 12, 2026 Feb 11, 2026
10-Q Quarterly report Feb 11, 2026 Dec 31, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
Dec 18, 2025 Dec 17, 2025
8-K Current report
Other events
Dec 15, 2025 Dec 12, 2025
S-8 Employee stock plan registration Dec 8, 2025 —
8-K Current report
Regulation FD disclosure
Nov 19, 2025 Nov 18, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
DEFA14A Additional proxy material Nov 3, 2025 —
DEF 14A Proxy statement Nov 3, 2025 Dec 17, 2025
PRE 14A Preliminary proxy statement Oct 24, 2025 Oct 24, 2025
10-K/A Amended annual report Oct 24, 2025 Jun 30, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 16, 2025 Oct 14, 2025
8-K Current report
Other events
Oct 14, 2025 Oct 10, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 14, 2025 Oct 9, 2025
8-K Current report
Regulation FD disclosure
Sep 23, 2025 Sep 23, 2025
8-K Current report
Other events
Sep 23, 2025 Sep 23, 2025
10-K Annual report Sep 23, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 5, 2025
424B3 Prospectus Aug 5, 2025 —
EFFECT Filing Aug 1, 2025 —
S-1/A Amended registration statement Aug 1, 2025 —
CORRESP Letter to the SEC Jul 31, 2025 —
8-K Current report
Regulation FD disclosure
Jul 28, 2025 Jul 28, 2025
CORRESP Letter to the SEC Jul 14, 2025 —
UPLOAD Letter from the SEC Jul 14, 2025 —
S-1 Registration statement Jul 9, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 30, 2025 Jun 24, 2025
8-K Current report
Regulation FD disclosure
Jun 24, 2025 Jun 24, 2025
8-K Current report
Material agreement, Auditor change, Shareholder vote results
Jun 13, 2025 Jun 12, 2025
DEFA14A Additional proxy material May 29, 2025 —
DEF 14A Proxy statement May 16, 2025 Jun 13, 2025
8-K Current report
Regulation FD disclosure
May 13, 2025 May 12, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
PRE 14A Preliminary proxy statement Apr 29, 2025 Apr 29, 2025
8-K Current report
Other events
Apr 25, 2025 Apr 25, 2025
8-K Current report
Other events
Apr 8, 2025 Apr 4, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 14, 2025 Feb 10, 2025
8-K Current report
Regulation FD disclosure
Feb 13, 2025 Feb 12, 2025
10-Q Quarterly report Feb 12, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Feb 3, 2025 Feb 3, 2025
8-K Current report
Regulation FD disclosure
Jan 22, 2025 Jan 22, 2025
8-K Current report
Regulation FD disclosure
Jan 21, 2025 Jan 21, 2025
424B3 Prospectus Jan 2, 2025 —
EFFECT Filing Dec 31, 2024 —
CORRESP Letter to the SEC Dec 30, 2024 —
S-1/A Amended registration statement Dec 30, 2024 —
UPLOAD Letter from the SEC Dec 27, 2024 —
S-1 Registration statement Dec 23, 2024 —
S-8 Employee stock plan registration Dec 20, 2024 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Dec 19, 2024 Dec 18, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Dec 18, 2024 Dec 13, 2024
8-K Current report
Regulation FD disclosure
Nov 20, 2024 Nov 19, 2024
8-K Current report
Regulation FD disclosure
Nov 15, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Change to shareholder rights, Regulation FD disclosure, Other events
Nov 12, 2024 Nov 8, 2024
8-K Current report
Listing notice, Regulation FD disclosure
Nov 5, 2024 Nov 1, 2024
DEF 14A Proxy statement Oct 28, 2024 Dec 18, 2024
8-K Current report
Regulation FD disclosure
Oct 28, 2024 Oct 28, 2024
DEFA14A Additional proxy material Oct 28, 2024 —
8-K Current report
Regulation FD disclosure
Oct 24, 2024 Oct 24, 2024
8-K Current report
Regulation FD disclosure
Oct 23, 2024 Oct 22, 2024
424B3 Prospectus Oct 17, 2024 —
8-K Current report
Regulation FD disclosure
Sep 30, 2024 Sep 30, 2024
10-K Annual report Sep 30, 2024 Jun 30, 2024
8-K Current report
Other events
Sep 26, 2024 Sep 26, 2024
8-K Current report
Listing notice, Regulation FD disclosure
Sep 20, 2024 Sep 17, 2024
8-K Current report
Regulation FD disclosure
Aug 21, 2024 Aug 21, 2024
8-K Current report
Regulation FD disclosure
Aug 20, 2024 Aug 20, 2024
8-K Current report
Regulation FD disclosure
Jul 30, 2024 Jul 30, 2024
8-K Current report
Material agreement
Jun 28, 2024 Jun 27, 2024
424B3 Prospectus Jun 28, 2024 —
8-K Current report
Regulation FD disclosure
Jun 11, 2024 Jun 10, 2024
8-K Current report
Regulation FD disclosure
May 14, 2024 May 14, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure
Apr 18, 2024 Apr 18, 2024
8-K Current report
Regulation FD disclosure
Apr 16, 2024 Apr 16, 2024
8-K Current report
Regulation FD disclosure
Apr 5, 2024 Apr 4, 2024
8-K Current report
Listing notice, Regulation FD disclosure
Mar 20, 2024 Mar 19, 2024
8-K Current report
Regulation FD disclosure
Feb 14, 2024 Feb 13, 2024
10-Q Quarterly report Feb 13, 2024 Dec 31, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 9, 2024 Feb 8, 2024
8-K Current report
Regulation FD disclosure
Jan 19, 2024 Jan 18, 2024
8-K Current report
Regulation FD disclosure
Jan 16, 2024 Jan 16, 2024
S-8 Employee stock plan registration Dec 22, 2023 —
10-K/A Amended annual report Dec 21, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results, Regulation FD disclosure
Dec 20, 2023 Dec 19, 2023
8-K Current report
Regulation FD disclosure
Nov 29, 2023 Nov 29, 2023
8-K Current report
Other events
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
EFFECT Filing Nov 13, 2023 —
424B3 Prospectus Nov 13, 2023 —
UPLOAD Letter from the SEC Nov 10, 2023 —
CORRESP Letter to the SEC Nov 9, 2023 —
S-1 Registration statement Nov 8, 2023 —
8-K Current report
Regulation FD disclosure
Nov 2, 2023 Nov 2, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 30, 2023 Oct 24, 2023
DEFA14A Additional proxy material Oct 27, 2023 —
DEF 14A Proxy statement Oct 27, 2023 Dec 19, 2023
8-K Current report
Regulation FD disclosure
Oct 24, 2023 Oct 24, 2023
8-K Current report
Regulation FD disclosure
Sep 29, 2023 Sep 29, 2023
10-K Annual report Sep 29, 2023 Jun 30, 2023
NT 10-K Notification of late filing Sep 29, 2023 Jun 30, 2023
8-K Current report
Other events
Sep 25, 2023 Sep 25, 2023
8-K Current report
Listing notice
Sep 25, 2023 Sep 22, 2023
8-K Current report
Regulation FD disclosure
Sep 8, 2023 Sep 7, 2023
8-K Current report
Regulation FD disclosure
Jul 24, 2023 Jul 21, 2023
8-K Current report
Regulation FD disclosure
Jul 20, 2023 Jul 20, 2023
8-K Current report
Regulation FD disclosure
Jun 22, 2023 Jun 22, 2023
8-K Current report
Regulation FD disclosure
Jun 1, 2023 Jun 1, 2023
8-K Current report
Regulation FD disclosure
May 25, 2023 May 24, 2023
8-K Current report
Regulation FD disclosure
May 19, 2023 Mar 18, 2023
8-K Current report
Regulation FD disclosure
May 16, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Regulation FD disclosure
Mar 28, 2023 Mar 28, 2023
8-K Current report
Regulation FD disclosure
Mar 14, 2023 Mar 13, 2023
8-K Current report
Regulation FD disclosure
Mar 7, 2023 Mar 6, 2023
8-K Current report
Regulation FD disclosure
Feb 21, 2023 Feb 17, 2023
10-Q Quarterly report Feb 17, 2023 Dec 31, 2022
NT 10-Q Notification of late filing Feb 10, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2023 Jan 10, 2023
8-K Current report
Shareholder vote results, Regulation FD disclosure
Dec 16, 2022 Dec 15, 2022
424B3 Prospectus Dec 15, 2022 —
EFFECT Filing Dec 14, 2022 —
8-K Current report
Other events
Dec 13, 2022 Dec 13, 2022
8-K Current report
Material agreement, Officer or director change, Other events
Dec 13, 2022 Dec 13, 2022
8-K Current report
Auditor change
Dec 13, 2022 Dec 8, 2022
CORRESP Letter to the SEC Dec 12, 2022 —
UPLOAD Letter from the SEC Dec 12, 2022 —
S-1 Registration statement Dec 7, 2022 —
D Filing Dec 6, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Nov 22, 2022 Nov 21, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 17, 2022 Nov 17, 2022
8-K Current report
Regulation FD disclosure
Nov 17, 2022 Nov 16, 2022
8-K Current report
Other events
Nov 15, 2022 Nov 11, 2022
S-8 Employee stock plan registration Nov 14, 2022 —
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
DEF 14A Proxy statement Oct 28, 2022 Dec 15, 2022
DEFA14A Additional proxy material Oct 28, 2022 —
8-K Current report
Regulation FD disclosure
Oct 26, 2022 Oct 26, 2022
424B3 Prospectus Oct 19, 2022 —
EFFECT Filing Oct 18, 2022 —
CORRESP Letter to the SEC Oct 14, 2022 —
UPLOAD Letter from the SEC Oct 14, 2022 —
S-1 Registration statement Oct 12, 2022 —
EFFECT Filing Oct 7, 2022 —
EFFECT Filing Oct 7, 2022 —
EFFECT Filing Oct 7, 2022 —
EFFECT Filing Oct 7, 2022 —
EFFECT Filing Oct 7, 2022 —
8-K Current report
Other events
Sep 29, 2022 Sep 29, 2022
10-K/A Amended annual report Sep 28, 2022 Jun 30, 2022
8-K Current report
Regulation FD disclosure
Sep 23, 2022 Sep 23, 2022
10-K Annual report Sep 23, 2022 Jun 30, 2022
8-K Current report
Regulation FD disclosure
Sep 20, 2022 Sep 19, 2022
S-8 POS Post-effective amendment no. 1 to form s-8 Sep 20, 2022 —
S-8 POS Post-effective amendment no. 1 to form s-8 Sep 20, 2022 —
POS AM Post-effective amendment no. 1 to form s-3 Sep 20, 2022 —
POS AM Post-effective amendment no. 1 to form s-3 Sep 20, 2022 —
POS AM Post-effective amendment no. 1 to form s-1 Sep 20, 2022 —
POS AM Post-effective amendment no. 1 to form s-1 Sep 20, 2022 —
POS AM Post-effective amendment no. 1 to form s-1 Sep 20, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 14, 2022 Sep 9, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
INM (Nasdaq)
Fiscal year ends
June 30
Incorporated in
British Columbia, Canada
Headquarters
Vancouver
SEC filer status
, Emerging growth company
SEC CIK
1728328

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.